Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Nyse  -  04:00:02 2023-03-24 pm EDT
33.85 USD   +1.62%
03/20Health Care Up as Banking Crisis Fears Abate -- Health Care Roundup
DJ
03/20Perrigo Recalls Baby Formula Due to Possible Contamination
DJ
03/18Nestlé Good Start Soothe Infant Formula recalled for potential bacteria contamination
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/20/2023 03/21/2023 03/22/2023 03/23/2023 03/24/2023 Date
34.95(c) 34.57(c) 33.98(c) 33.31(c) 33.85(c) Last
1 232 005 1 886 680 1 387 304 1 107 320 832 698 Volume
+0.52% -1.09% -1.71% -1.97% +1.62% Change
More quotes
Estimated financial data (e) (USD)
Sales 2023 4 794 M - -
Net income 2023 -17,4 M - -
Net Debt 2023 3 312 M - -
P/E ratio 2023 -260x
Yield 2023 3,23%
Sales 2024 4 983 M - -
Net income 2024 34,7 M - -
Net Debt 2024 3 041 M - -
P/E ratio 2024 135x
Yield 2024 3,55%
Capitalization 4 558 M 4 558 M -
EV / Sales 2023 1,64x
EV / Sales 2024 1,52x
Nbr of Employees 8 900
Free-Float 99,0%
More Financials
Company
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United... 
Sector
Pharmaceuticals
Calendar
05/09Earnings Release
More about the company
Ratings of Perrigo Company plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about PERRIGO COMPANY PLC
03/20Health Care Up as Banking Crisis Fears Abate -- Health Care Roundup
DJ
03/20Perrigo Recalls Baby Formula Due to Possible Contamination
DJ
03/18Nestlé Good Start Soothe Infant Formula recalled for potential bacteria contamination
AQ
03/15Transcript : Perrigo Company plc Presents at UBS 12th Annual Global Consumer ..
CI
03/14Insider Sell: Perrigo Co
MT
03/14Insider Sell: Perrigo Co
MT
03/09PERRIGO COMPANY PLC : Ex-dividend day for
FA
03/07Canaccord Genuity Starts Perrigo at Buy With $49 Price Target
MT
03/07Insider Buy: Perrigo Co
MT
03/06Raymond James Adjusts Perrigo Price Target to $43 From $42, Maintains Outperform Rating
MT
03/02Perrigo to Present at Upcoming 12th Annual UBS Global Consumer and Retail Conference
PR
03/01Perrigo Obtains US FDA Approval for Tablets With Acetaminophen, Ibuprofen
MT
03/01Perrigo Announces FDA Approval of the Store Brand OTC Equivalent of Advil« Dual Action ..
PR
03/01Perrigo Company plc Announces FDA Approval of the Store Brand OTC Equivalent of Advil(R..
CI
02/28Target, Perrigo rise; Norwegian, Universal Health fall
AQ
More news
News in other languages on PERRIGO COMPANY PLC
03/14Vente d'initié : Perrigo Co
03/14Vente d'initié : Perrigo Co
03/14Biocorp: accord avec HRA Pharma pour développer un nouveau dispositif médical
03/14BIOCORP : avec HRA pour un dispositif de cicatrisation
03/14Les valeurs à suivre aujourd'hui à la Bourse de Paris - Mardi 14 mars 2023
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
ETFs positioned on PERRIGO COMPANY PLCETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Rize Medical Cannabis and Life Sciences Acc - USD15.47%-1.14%-World
AGFiQ US Market Neutral Anti-Beta Fund - USD15.31%0.88%United_States
SPDR S&P Pharmaceuticals ETF - USD4.92%-1.23%United_States
Invesco Dynamic Pharmaceuticals ETF - USD3.88%0.70%United_States
VanEck Pharmaceutical ETF - USD1.44%2.17%United_States
More ETFs positioned on PERRIGO COMPANY PLC
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 33,85 $
Average target price 48,20 $
Spread / Average Target 42,4%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Eduardo Guarita Bezerra Chief Financial Officer & Executive Vice President
Orlando D. Ashford Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC-0.70%4 558
JOHNSON & JOHNSON-13.59%398 966
NOVO NORDISK A/S11.83%340 729
ELI LILLY AND COMPANY-8.12%303 155
ABBVIE INC.-2.22%278 770
MERCK & CO., INC.-5.54%266 044
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer